Different mechanisms of lysophosphatidylcholine-induced Ca2+ mobilization in N2a mouse and SH-SY5Y human neuroblastoma cells

Neuroscience Letters

Volumn 424, Issue 1, 2007, Pages 22-26

  Li, Xiao Hua ^a,b   Long, Ding Xin ^a,b   Li, Wei ^a   Wu, Yi Jun ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Delayed neurotoxicity; Extracellular Ca2+ influx; Intracellular Ca2+ level; Lysophosphatidylcholine; Membrane detergent action; Neuroblastoma cell

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DETERGENT; LYSOPHOSPHATIDYLCHOLINE; ORGANOPHOSPHATE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL LINE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DEMYELINATION; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; MOLECULAR DYNAMICS; MOUSE; MOUSE STRAIN; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTRACELLULAR FLUID; LYSOPHOSPHATIDYLCHOLINES; MICE; NERVOUS SYSTEM; NEURONS; PHOSPHORIC ACID ESTERS; SPECIES SPECIFICITY;

EID: 34548023945     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.07.020     Document Type: Article

References (26)

1. Abou-Donia M.B., and Lapadula D.M. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 405-440
2. Bouldin T.W., and Cavanagh J.B. Organophosphorous neuropathy. I. A teased-fiber study of the spatio-temporal spread of axonal degeneration. Am. J. Pathol. 94 (1979) 241-252
3. Choudhary S., and Gill K.D. Protective effect of nimodipine on dichlorvos-induced delayed neurotoxicity in rat brain. Biochem. Pharmacol. 62 (2001) 1265-1272
4. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
5. Hall S.M. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J. Cell Sci. 10 (1972) 535-546
6. Iqbal K., Alonso Adel C., El-Akkad E., Gong C.X., Haque N., Khatoon S., Pei J.J., Tanimukai H., Tsujio I., Wang J.Z., and Grundke-Iqba I. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays. J. Mol. Neurosci. 20 (2003) 425-429
7. Jean I., Allamargot C., Barthelaix-Pouplard A., and Fressinaud C. Axonal lesions and PDGF-enhanced remyelination in the rat corpus callosum after lysolecithin demyelination. Neuroreport 13 (2002) 627-631
8. Johnson M.K. The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Biochem. J. 114 (1969) 711-714
9. Kostrzewa R.M., and Segura-Aguilar J. Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection, a review. Neurotox. Res. 5 (2003) 375-383
10. Mohandas N., Wyatt J., Mel S.F., Rossi M.E., and Shohet S.B. Lipid translocation across the human erythrocyte membrane. J. Biol. Chem. 257 (1982) 6537-6543
11. 2+ system in HL-60 leukaemia cells. Biochem. J. 336 (1998) 491-500
12. Quinn M.T., Parthasarathy S., and Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA 85 (1988) 2805-2809
13. Quistad G.B., Barlow C., Winrow C.J., Sparks S.E., and Casida J.E. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc. Natl. Acad. Sci. USA 100 (2003) 7983-7987
14. Quistad G.B., and Casida J.E. Lysophospholipase inhibition by organophosphorus toxicants. Toxicol. Appl. Pharmacol. 196 (2004) 319-326
15. Saunders L. Molecular aggregation in aqueous dispersion of phosphatidyl and lysophosphatidyl cholines. Biochem. Biophys. Acta 125 (1996) 70-74
16. Schlaepfer W.W. Neurofilaments: structure, metabolism and implication in disease. J. Neuropathol. Exp. Neurol. 46 (1987) 117-129
17. Schlaepfer W.W., and Hasler M.B. Characterization of the calcium-induced disruption of neurofilaments in rat peripheral nerve. Brain Res. 168 (1979) 299-309
18. Sedlis S.P., Hom M., Sequeira J.M., and Esposito R. Lysophosphatidylcholine accumulation in ischemic human myocardium. J. Lab. Clin. Med. 121 (1993) 111-117
19. Silverman B.A., Weller P.F., and Shin M.L. Effect of erythrocyte membrane modulation by lysolecithin on complement-mediated lysis. J. Immunol. 132 (1984) 381-391
20. Smith K.J., and Hall S.M. Central demyelination induced in vivo by the calcium ionophore ionomycin. Brain 117 (1994) 1351-1356
21. Smith K.J., and Hall S.M. Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations. J. Neurol. Sci. 83 (1988) 37-53
22. Vidaver G.A., Ting A., and Lee J.W. Evidence that lysolecithin is an important causal agent of atherosclerosis. J. Theor. Biol. 115 (1985) 27-41
23. Wang A., Deems R.A., Dennis E.A., and Cloning. expression, and catalytic mechanism of murine lysophospholipase I. J. Biol. Chem. 272 (1997) 12723-12729
24. Weltzien H.U. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta 559 (1979) 259-287
25. Wu S.Y., and Casida J.E. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors. Toxicol. Appl. Pharmacol. 139 (1996) 195-202
26. Yu L., Netticadan T., Xu Y.J., Panagia V., and Dhalla N.S. Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J. Pharmacol. Exp. Ther. 286 (1998) 1-8